Introduction
============

Radical cystectomy is the standard treatment for localized muscle-invasive bladder cancer (MIBC) ([@b1-etm-0-0-8111],[@b2-etm-0-0-8111]). Urinary diversion methods post-radical cystectomy include abdominal, urethral and rectosigmoid diversions. Urinary diversion has evolved along three distinct paths: Incontinent cutaneous diversion (conduit); continent cutaneous diversion (pouch); and, most recently, continent urinary diversion to the intact native urethra (neobladder, orthotopic reconstruction) ([@b2-etm-0-0-8111]). Continent urinary diversion has been revealed to improve the quality of life of patients post-cystectomy and is preferred by most urologists and patients ([@b3-etm-0-0-8111]). Conduit urinary diversions fall into two categories: Those using the small bowel, including the jejunum or ileum; and those using a part of the colon ([@b4-etm-0-0-8111]).

The sigma-rectum pouch (Mainz pouch II), first described by Fisch *et al* in 1993 ([@b5-etm-0-0-8111]), is a relatively safe and simple system for urinary diversion. The procedure allows for continent urinary diversion into a low-pressure, high-capacity reservoir created using the rectosigmoid colon ([@b6-etm-0-0-8111]). Hyperchloremic acidosis and electrolyte disturbances that lead to metabolic disorders (owing to the absorption of urinary metabolites by the intestinal mucosa) are one possible complication of sigma-rectum pouch surgery and require treatment with oral medication ([@b5-etm-0-0-8111],[@b7-etm-0-0-8111],[@b8-etm-0-0-8111]). Patients with severe metabolic disorders, which do not respond to drugs, can suffer extensive damage to renal function that eventually threatens their life ([@b8-etm-0-0-8111]).

Between July 2011 and April 2015, a total of six male patients afflicted with recurrent hyperchloremic metabolic acidosis, hypokalemia and renal dysfunction after receiving sigma-rectum pouch surgery, underwent urinary undiversion surgery from a sigma-rectum pouch to a cutaneous urinary stoma at BenQ Medical Center, with satisfactory results. All patients were informed of the risk of unpredictable surgical outcomes and complications prior to the surgery. On agreeing to participate they signed informed consent forms and the surgery was approved by the Medical Ethics Review Committee of BenQ Medical Center (approval no. 2011072102).

Case report
===========

### Patient data

A total of six male patients, aged 58--82 years (median age, 70 years), underwent radical cystectomy and sigma-rectum pouch surgery due to MIBC 2--5 years prior to admission to the Urology Department of BenQ Medical Center. Recurrent fatigue and anorexia 1--4 years post-operatively had been complained by all patients. Blood gas analysis (WERi-STAT300; Abbott Pharmaceutical Co., Ltd.) and biochemical tests (Bs-390; MINDRAY Medical International Co., Ltd.) indicated hyperchloremic metabolic acidosis (hydrocarbonate \<21 mmol/l; pH \<7.35; chlorine \>106 mmol/l) and hypokalemia (potassium \<3.5 mmol/l), with two patients additionally suffering from hypocalcemia (calcium \<2.1 mmol/l). Oral administration of sodium bicarbonate (1.0 g; three times per day) and potassium citrate (1.45 g; three times per day) led to a poor therapeutic effect in all patients, who needed additional intravenous bicarbonate (2--5 mmol/kg) and potassium salt (40--60 mmol/day) supplements to correct the acidosis and hypokalemia. The interval requiring intravenous rehydration was gradually shortened. In one case, the patient suffered severe paralytic ileus, leading to loss of consciousness. At 1 week prior to the operation, the arterial blood pH, hydrocarbonate (HCO3^−^), base excess, serum potassium level, chlorine, urea nitrogen and creatinine were 7.16±0.08 (normal range 7.35--7.45), 7.57±4.25 mmol/l (normal range 21--26 mmol/l), −19.68±4.85 mmol/l (normal range −3-3 mmol/l), 3.12±0.21 mmol/l (normal range 3.5--5.5 mmol/l), 110.90±4.38 mmol/l (normal range 96--106 mmol/l), 20.15±3.77 mmol/l (normal range 3.2--7.1 mmol/l) and 304.67±55.58 µmol/l (normal range 53--106 µmol/l), respectively. Ultrasound revealed two cases of mild hydronephrosis (renal sinus separated 21 mm), three cases of moderate hydronephrosis (renal sinus separated 32--38 mm) and one of unilateral severe hydronephrosis (renal sinus separated 45 mm). Two patients suffered retrograde infection and were treated with unilateral nephrostomy and nephrectomy, respectively.

### Preoperative preparation

At 1 week prior to the operation, intravenous infusion of 5% sodium bicarbonate and 10% potassium chloride solutions was administered to treat acidosis and hypokalemia. Dynamic blood gas analysis and electrolyte and renal function assessments were carried out to monitor patient status. From 2 days prior to the surgery, the patients were allowed only a liquid diet. Levofloxacin (500 mg) and tinidazole (1,000 mg) were administered orally. A cleansing enema was organized the night prior to the surgery. Intravenous infusion of 2.0 g ceftriaxone sodium was used with general anesthesia to prevent infection.

### Operation procedure

Pouch ostomy on the abdominal wall and sigmoid-rectal anastomosis were performed under combined intravenous and inhalation anesthesia (propofol 2.0 mg/kg intravenous for induction; sevoflurane 1.0--2.0 vol% inhalation and remifentanil 0.3 µg/kg/min intravenous for maintenance), in the lithotomy position. A lower midline, 2-cm long, abdominal incision was made from below the umbilicus to the symphysis pubis. The pouch, sigmoid colon and rectum were mobilized, and the mesenteric blood supply was carefully protected. The sigmoid colon was cut at the junction of sigmoid colon and pouch using a disposable linear cutter stapler (Sinolinks Medical Innovation, Inc.) and the rectum below the uretero-pouch anastomosis was cut using a disposable curved cutter (Sinolinks Medical Innovation, Inc.; [Fig. 1A](#f1-etm-0-0-8111){ref-type="fig"}). End-to-end anastomosis of the sigmoid colon and rectum was performed on the left of the pouch with a tubular anastomat, after dilating the anal sphincter. The integrity of removed bowels, whether the anastomosed intestine was tension-free, and the patency of intestinal anastomosis were assessed. To reinforce the intestinal anastomosis, interrupted seromuscular inverting suture was performed. The pouch was opened ventrally. The ureter-pouch anastomosis was dilated and a 7 Fr single pig-tail stent (Well Lead Medical Co., Ltd.) was implanted for patients with moderate to severe hydronephrosis. The pouch was pulled out of the abdominal wall; interrupted suture was used to suture the peritoneum with serosa and the aponeurosis of obliquus externus abdominis muscle with seromuscular tissue. The entire layer of the opening of the pouch was sutured to the skin and a 26 Fr mushroom catheter (Well Lead Medical Co., Ltd.) was inserted into the pouch for drainage ([Fig. 1B](#f1-etm-0-0-8111){ref-type="fig"}).

### Post-operative care

Ceftriaxone sodium (2.0 g) and parenteral nutrition were given intravenously in the immediate days postoperatively, until a liquid diet was permitted (4--5 days later). Arterial blood gases, serum electrolytes and renal function were measured 1 week post-operatively. The single J stent was removed 2 weeks post-surgery. An EC two-piece urinary tract ostomy pocket (60 mm; Coloplast, Ltd.) covered the stoma, and the catheter was shortened so as to fit easily into the pocket ([Fig. 2](#f2-etm-0-0-8111){ref-type="fig"}), and was replaced monthly.

### Follow up

Follow-ups were carried out at 3 and 6 months, 1, 2, and 3 years post-surgery. Arterial blood gas analysis, serum electrolytes and renal function were monitored without sodium bicarbonate and/or potassium citrate treatment. Preoperative and postoperative data were compared. The quality of life index and general health condition of the patients was evaluated at 1 year post-surgery using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) C-30 survey ([@b9-etm-0-0-8111]).

### Statistical analysis

Data are presented as the mean ± standard deviation. ANOVA of single-factor repeated measurement data was performed to ascertain the significant differences, followed by bonferronis method, between the pre- and post-surgery data using SPSS statistics 20.0 software (IBM Corp.). P\<0.05 was considered to indicate a statistically significant difference.

### Surgical outcomes

The duration of the surgery was in the range of 230--290 min, averaging to 255.00±20.74 min. Intraoperative blood loss was in the range of 40--300 ml, averaging to 161.67±89.09 ml. No surgery-related complications, such as dehiscence of the bowel anastomosis, urinary leakage, infections or thrombotic events, were observed.

Data from the blood gas, electrolyte and renal function analysis are shown in [Table I](#tI-etm-0-0-8111){ref-type="table"}. Arterial blood gas analysis indicated: i) No significant difference between the blood pH 3 months post-surgery and preoperatively, though pH was found to recover and remain normal (between 7.35 and 7.45) until 6 months later; and ii) the hydrocarbonate and base excess levels were both significantly different at 6 months and 3 years post-surgery compared with the preoperative levels (P\<0.05). At 1--2 years later, the data had reached normal levels, with hydrocarbonate between 21 and 26 mmol/l and base excess between −3 and 3 mmol/l.

Blood potassium was found to be higher 3 months post-surgery compared with the preoperative levels, and was statistically different from 6 months post-surgery (P\<0.05), and remained normal (between 3.5 and 5.5 mmol/l) over the follow-up period of 1 to 2 years. Blood chlorine recovered slowly and decreased significantly over the 3 years post-operation (P\<0.05). However, improvement in renal function was not ideal. The results of urea nitrogen improved 6 months post-operatively compared with pre-operative levels (P\<0.05), but concentration at the 2 years follow-up was slightly higher than at the 1 year\'s follow-up, though still significantly lower than that pre-operatively. Serum creatinine was found to be statistically different from 6 months post-operatively compared with pre-operatively (P\<0.05), but did not normalize (53--106 µmol/l) until 3 years post-surgery ([Table I](#tI-etm-0-0-8111){ref-type="table"} and [Fig. 3](#f3-etm-0-0-8111){ref-type="fig"}).

The catheter was replaced once per month. All patients had normal defecation. No severe acidosis or electrolyte disturbances occurred during the 3 years of follow-up and the serum creatinine levels remained stable between 162 and 203 µmol/l. All patients acquired satisfactory health status according to the results of EORTC QLQ C-30 survey (data not shown). Though one patient had poor life quality, most patients were satisfied with their quality of life post-surgery.

Discussion
==========

Fisch *et al* ([@b5-etm-0-0-8111]) described a variation of ureterosigmoidostomy in 1990s. This surgery, termed the sigma-rectum or the Mainz II pouch, creates a low-pressure rectosigmoid reservoir of increased capacity. Its major advantages are the simplicity and reproducibility of the operation. Several studies have demonstrated that sigma-rectum pouch is a safe and acceptable procedure for urinary diversion, with high continence rates and a low incidence of complications ([@b10-etm-0-0-8111],[@b11-etm-0-0-8111]). Nevertheless, nocturnal urinary incontinence, retrograde renal pelvis infection, ureteral-intestinal anastomotic stenosis, hyperchloremic metabolic acidosis, hypokalemia and impaired renal function are common complications occurring as a result of this procedure ([@b12-etm-0-0-8111]--[@b15-etm-0-0-8111]).

Oral administration of sodium bicarbonate has been revealed to significantly reduce the incidence of metabolic acidosis after sigma-rectum pouch surgery ([@b14-etm-0-0-8111],[@b16-etm-0-0-8111]). Most patients exhibit mild symptoms post-surgery. Severe symptoms, manifesting as fatigue, anorexia, weight loss, polydipsia or lethargy, are rare. If these symptoms persist, they can lead to severe metabolic disorders and may even be life-threatening ([@b16-etm-0-0-8111]). The absorption of urine in the intestine and damage to renal function are the main causes of metabolic disturbance after sigma-rectum pouch surgery. The mechanism of hyperchloremic metabolic acidosis has been revealed to be the ionized transport of ammonium, which substitutes for sodium in the Na^+^-H^+^ antiport ([@b12-etm-0-0-8111]). The exchange of the weak acid NH~4~ for a proton is coupled with the exchange of bicarbonate for chloride. Thus, NH~4~Cl is absorbed across the lumen into the blood in exchange for H~2~CO~3~ (CO~2~ and water). Ammonium may also enter the blood from the bowel lumen through potassium channels ([@b12-etm-0-0-8111]). Hypokalemia or the total-body depletion of potassium is found to be more common in patients with ureterosigmoidostomy than in patients who undergo other types of urinary intestinal diversion ([@b14-etm-0-0-8111]). Patients most susceptible to total-body potassium depletion have been shown to be those with long-standing uncorrected metabolic acidosis ([@b17-etm-0-0-8111]). Potassium depletion may be due to renal potassium wasting, as a result of renal damage, osmotic diuresis and gut loss through intestinal secretion. Postoperative renal damage is thought to be related to hydronephrosis, caused by the lack of ureteral motility and the stenosis of ureterointestinal anastomosis ([@b12-etm-0-0-8111]).

The metabolite content of urine absorbed by the intestinal mucosa is determined by several factors, including the selected intestinal segment and its area, the residence time of urine in the pouch, urine osmotic pressure, urine pH value and liver function, in conjunction with overlong voiding intervals, particularly the long-term contact of urine with the intestinal mucosa due to urine reflux and storage in the descending colon at night ([@b12-etm-0-0-8111]).

Hyperchloremic metabolic acidosis can be treated by administering a potassium supplement, alkalizing agents and blockers of chloride transport ([@b18-etm-0-0-8111]). However, in cases of severe dysbolism that do not respond to conventional drug treatment, further damage to renal function can occur, forming a vicious cycle. The results of this case report suggested that surgical intervention to reduce urine absorption in the intestine and improve renal function might represent the best option to save the lives of these patients. Although the average serum creatinine level did not decrease to normal level (53--106 µmol/l) following surgery, and patients who had undergone unilateral nephrectomy due to retrograde infection may also be one of the reasons why the serum creatinine did not reach normal level.

Urinary undiversion from a sigma-rectum pouch to a cutaneous urinary stoma separates the pouch from the intestinal tract and creates a stoma on the abdominal wall for continuous urine discharge, without interfering with normal defecation (similar to colon conduit). This procedure reduces the surface contact area of the intestinal mucosa with urine and the residence time of urine in the intestinal tract. The metabolites from urine are then not so easily absorbed by the intestinal mucosa, so acidosis and electrolyte disturbances can be corrected. During the surgery, the stenotic ureter-pouch anastomosis was expanded, to decrease hydronephrosis, thereby improving renal function. This urinary undiversion procedure is an alternative treatment for severe complications following sigma-rectum pouch surgery.

The major preoperative preparations were correcting acidosis and electrolyte disorders and improving the general condition of patients. Bowel preparation was performed as for routine intestinal surgery. Bleeding and surrounding visceral injury can easily be caused during the urinary undiversion operation, due to adhesion and changes in local anatomical structure. However, no massive hemorrhage or other surgery-related complications were observed in the six patients. To ensure the best outcomes it was recommended that attention was paid to the following points during surgery: i) The posterior rectus sheath, if directly cut from the original incision, could easily damage the adherent intestinal canal below; therefore the rectus abdominis was pulled outward to expose the posterior rectus sheath following the opening of the anterior sheath, then the abdominal cavity was entered from the upper part of the incision without adhesion and the adherent posterior sheath and small intestine were isolated. ii) The descending colon was identified and dissected downward to the pouch, and the small intestine adhering to the pouch was separated; \~5 cm of the distal part of the pouch was then freed in order to ease the tension-free anastomosis of the sigmoid colon with the rectum. During the separation process the blood supply of the pouch was protected. iii) The mesentery supplying blood to the pouch was moderately freed so that the pouch could be pulled out of the abdominal stoma. iv) The ureters were not isolated outside of the pouch to avoid injury and influencing the blood supply due to severe adhesion around the anastomotic stomas. v) The pouch was opened and the ureteric orifice located. Injection of 10 ml methylene blue intravenously was performed if it was difficult to identify the orifice. The anastomotic stoma was dilated in patients with stricture and a 7 Fr single J tube implanted for 2 weeks to relieve hydronephrosis. vi) The cutaneous diversion was incontinent. Urine retention and infection are the main causes of stone formation ([@b19-etm-0-0-8111]). Therefore, a 26 Fr mushroom catheter was inserted in the stoma for constant drainage to reduce the residence time of urine in the pouch.

In conclusion, urinary undiversion from sigma-rectum pouch to cutaneous urinary stoma exhibited a therapeutic effect in six patients with severe metabolic disorders after sigma-rectum pouch surgery. However, the long-term effectiveness of this procedure is yet to be confirmed and more data are needed to establish its benefit. Of the hundreds of patients who have undergone sigma-rectum pouch surgery at BenQ Medical Center, only very few have been observed to suffer from serious metabolic disorders, which are complications that need attention and timely correction. Surgical treatment is recommended to improve patient quality of life, and urinary undiversion surgery may be an effective option.
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![Schematic representation of the pouch ostomy on the abdominal wall and sigmoid-rectal anastomosis. (A) Schematic of the sigma-rectal pouch. Dotted lines indicate incision lines between the pouch and sigmoid colon and rectum. (B) The pouch was isolated from the intestinal tract and an abdominal ostomy was made. The sigmoid colon and rectum were rejoined to recover intestinal continuity.](etm-18-06-4881-g00){#f1-etm-0-0-8111}

![Images of the abdominal stoma after undiversion surgery. (A) The stoma. (B) A 26 Fr mushroom catheter was inserted into the pouch for continuous drainage. (C) The stoma was covered by ostomy pocket.](etm-18-06-4881-g01){#f2-etm-0-0-8111}

![Statistical charts of the results for arterial blood gas analysis, serum electrolytes and renal function at 1 week preoperatively and 3 months to 3 years postoperatively. Line graphs show changing trends in parameters of (A) arterial blood gas analysis, (B) electrolyte analysis and (C) renal function between 1 week preoperatively and 3 years postoperatively. \*P\<0.05 vs. the respective 1 week pre-operation group. 1, 1 week pre-operation; 2, 3 months post-operation; 3, 6 months post-operation; 4, 1 year post-operation; 5, 2 years post-operation; 6, 3 years post-operation. Error bars are the 95% confidence intervals. BE, base excess.](etm-18-06-4881-g02){#f3-etm-0-0-8111}

###### 

Results for arterial blood gas analysis, serum electrolytes and renal function at 1 week preoperatively and 3 months to 3 years postoperatively (mean ± SD).

  Analysis                      Parameters                 Follow-up time            Results                                                      P-value
  ----------------------------- -------------------------- ------------------------- ------------------------------------------------------------ ---------
  Arterial blood gas analysis   pH                         1 week pre-operation      7.16±0.08                                                    --
                                                           3 months post-operation   7.31±0.09                                                    1.000
                                                           6 month post-operation    7.36±0.04^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^      0.028
                                                           1 year post-operation     7.42±0.02^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^      0.005
                                                           2 years post-operation    7.42±0.01^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^      0.009
                                                           3 years post-operation    7.42±0.02^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^      0.006
                                Hydrocarbonate, mmol/l     1 week pre-operation      7.57±4.25                                                    --
                                                           3 months post-operation   17.90±4.12^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^     0.026
                                                           6 month post-operation    19.72±5.26^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^     0.022
                                                           1 year post-operation     22.72±2.39^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^     0.005
                                                           2 years post-operation    24.78±1.17^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^     0.001
                                                           3 years post-operation    25.03±0.67^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^     0.001
                                BE, mmol/l                 1 week pre-operation      −19.68±4.85                                                  --
                                                           3 months post-operation   −7.27±4.31                                                   0.064
                                                           6 month post-operation    −4.77±5.42^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^     0.022
                                                           1 year post-operation     −1.30±1.59^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^     0.003
                                                           2 years post-operation    0.50±1.25^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^      0.001
                                                           3 years post-operation    0.32±1.26^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^      0.001
  Serum electrolytes            Potassium, mmol/l          1 week pre-operation      3.12±0.21                                                    --
                                                           3 months post-operation   4.05±0.69                                                    0.481
                                                           6 month post-operation    3.95±0.38^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^      0.032
                                                           1 year post-operation     4.30±0.22^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^      0.012
                                                           2 years post-operation    4.08±0.35^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^      0.038
                                                           3 years post-operation    3.78±0.23^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^      0.039
                                Chlorine, mmol/l           1 week pre-operation      110.90±4.38                                                  --
                                                           3 months post-operation   107.60±3.68                                                  1.000
                                                           6 month post-operation    107.08±4.39                                                  1.000
                                                           1 year post-operation     105.82±3.12                                                  0.526
                                                           2 years post-operation    101.43±5.61                                                  0.184
                                                           3 years post-operation    99.17±2.75^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^     0.038
  Renal function                Urea nitrogen, mmol/l      1 week pre-operation      20.15±3.77                                                   --
                                                           3 months post-operation   19.52±3.45                                                   0.745
                                                           6 month post-operation    12.32±3.46^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^     0.004
                                                           1 year post-operation     9.40±2.40^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^      0.001
                                                           2 years post-operation    10.10±1.16^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^     0.041
                                                           3 years post-operation    9.87±1.42^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^      0.026
                                Serum creatinine, µmol/l   1 week pre-operation      304.67±55.58                                                 --
                                                           3 months post-operation   271.17±31.90                                                 0.115
                                                           6 month post-operation    213.00±44.85^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^   0.028
                                                           1 year post-operation     197.33±33.34^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^   0.027
                                                           2 years post-operation    194.33±27.12^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^   0.028
                                                           3 years post-operation    181.50±15.51^[a](#tfn1-etm-0-0-8111){ref-type="table-fn"}^   0.026

P\<0.05 vs. respective data 1 week pre-operation. BE, base excess.
